Cleared Abbreviated

K112603 - ACCESS HYBRITECH P2PSA QC ON THE ACCESS IMMUNOASSAY SYSTEMS (FDA 510(k) Clearance)

Nov 2011
Decision
58d
Days
Class 1
Risk

K112603 is an FDA 510(k) clearance for the ACCESS HYBRITECH P2PSA QC ON THE ACCESS IMMUNOASSAY SYSTEMS. This device is classified as a Single (specified) Analyte Controls (assayed And Unassayed) (Class I - General Controls, product code JJX).

Submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on November 4, 2011, 58 days after receiving the submission on September 7, 2011.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 862.1660.

Submission Details

510(k) Number K112603 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 2011
Decision Date November 04, 2011
Days to Decision 58 days
Submission Type Abbreviated
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code JJX — Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1660